We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Cepheid Faces More Backlash over TB Test Price and Access
Cepheid Faces More Backlash over TB Test Price and Access
Sunnyvale, Calif.-based molecular diagnostics company Cepheid is embroiled in a controversy over access in developing countries to its tuberculosis diagnostics test, which was funded in part by the World Health Organization (WHO).